8:45am ET
Investing
Insiders Bet Big on These 3 Fintech and Biotech Stocks
In the past week or so, a fintech firm and two biotechs saw some huge insider buying. However, these were not the only notable insider purchases recently.
Companies
/Healthcare
Mineralys Therapeutics Inc
$26.15
â–² $0.26 (+1.01%) today
Markets open · 1:43pm ET
Today · % change
Fundamentals
Market Cap
$2.3B
EPS (TTM)
$-4.20
52-Week Range
$15 – $48
Street Target
$48.50
About Mineralys Therapeutics
Mineralys Therapeutics, based in Radnor, Pennsylvania, is a biopharmaceutical company focused on creating treatments for hypertension and related cardiovascular conditions. Founded in 2019, it's at the forefront with its leading product, lorundrostat, an innovative oral medication designed to selectively inhibit aldosterone synthase, aiming to help patients with hypertension that's difficult to control with existing therapies.
MLYS Coverage
8:45am ET
Investing
Insiders Snap Up $54M in Biotech and Offshore Driller Stocks
In the past week or so, some public offerings prompted huge insider buying. However, these were not the only notable insider purchases recently.
8:45am ET
Investing
Carl Icahn Buys More Shares, and Tesla Insider Bucks the Selling Trend
Though insider buying has slowed during the first-quarter earnings reporting season, some insiders continued to build stakes or bucked selling trends.